Yang Fu
Impact in
-
- Hepatitis C virus research
-
- Venous Thromboembolism Diagnosis and Management
Papers in
- Epidemiology 12
- Hepatitis B Virus Studies 3
- Autophagy in Disease and Therapy 3
- Sepsis Diagnosis and Treatment 3
- Co-authors
- Lanlan Wang (6 shared papers)Chunlin Zhao (1 shared paper)Hongyu Zhang (1 shared paper)Nan Sun (1 shared paper)Miao Song (2 shared papers)Feibo Xu (2 shared papers)Zheng Cao (2 shared papers)Yanfei Li (2 shared papers)
In The Last Decade
Yang Fu
33 papers receiving 431 citations
Peers
Comparison fields: 5 of 90
- Hepatology 51
- Internal Medicine 23
- Immunology 88
- Oncology 85
- Molecular Medicine 13
Countries citing papers authored by Yang Fu
This map shows the geographic impact of Yang Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yang Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yang Fu more than expected).
Fields of papers citing papers by Yang Fu
This network shows the impact of papers produced by Yang Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yang Fu. The network helps show where Yang Fu may publish in the future.
Co-authors
The 25 scholars most cited alongside Yang Fu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 49 | |
| 2 | 2014 | 43 | |
| 3 | 2004 | 42 | |
| 4 | 2022 | 32 | |
| 5 | 2021 | 29 | |
| 6 | 2022 | 27 | |
| 7 | 2015 | 25 | |
| 8 | 2012 | 21 | |
| 9 | 2018 | 21 | |
| 10 | Transarterial chemoembolization (TACE) plus percutaneous ethanol injection (PEI) for the treatment of unresectable hepatocellular carcinoma: a meta-analysis of randomized controlled trials. | 2015 | 17 |
| 11 | 2015 | 14 | |
| 12 | 2022 | 14 | |
| 13 | 2020 | 12 | |
| 14 | 2021 | 12 | |
| 15 | 2013 | 12 | |
| 16 | 2013 | 9 | |
| 17 | 2019 | 9 | |
| 18 | 2022 | 6 | |
| 19 | 2020 | 5 | |
| 20 | 2024 | 5 |
About Yang Fu
Yang Fu is a scholar working on Epidemiology, Molecular Biology, Surgery, Oncology and Immunology, having authored 37 papers that have together received 440 indexed citations. Recurring topics across this work include Venous Thromboembolism Diagnosis and Management (5 papers), Clusterin in disease pathology (3 papers), Hepatitis B Virus Studies (3 papers), Neutropenia and Cancer Infections (3 papers), Autophagy in Disease and Therapy (3 papers), Inflammation biomarkers and pathways (3 papers), Hepatitis C virus research (3 papers) and Sepsis Diagnosis and Treatment (3 papers). The work is most often cited by research in Hepatology (51 citations), Internal Medicine (23 citations), Immunology (88 citations), Oncology (85 citations) and Molecular Medicine (13 citations). Yang Fu has collaborated with scholars based in China, Australia and Taiwan. Frequent co-authors include Lanlan Wang, Chunlin Zhao, Hongyu Zhang, Nan Sun, Miao Song, Feibo Xu, Zheng Cao, Yanfei Li, Chuchu Zhang and Yi Li. Their work appears in journals such as Journal of Pediatric Hematology/Oncology, Inflammation Research, Infection and Drug Resistance, Hepatology International and Cardiovascular Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.